Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Systems Biology Group (SBG) is a biotechnology and research services company that specializes in Quantitative Systems Pharmacology (QSP) and mechanistic modeling to support drug discovery and development. The company provides advanced computational modeling services to pharmaceutical and biotech partners, helping to predict drug efficacy, safety, and optimal dosing regimens before clinical trials. By integrating multi-omics data with physiological models, SBG enables a deeper understanding of disease mechanisms and drug-target interactions. Their expertise spans across multiple therapeutic areas, including oncology, metabolic disorders, and immunology, offering both consulting services and proprietary software solutions for complex biological simulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Systems Biology Group Lab.